Browse our anti-CDKN2D (CDKN2D) Antibodies

Full name:
anti-Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) Antibodies (CDKN2D)
On are 73 Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) Antibodies from 18 different suppliers available. Additionally we are shipping CDKN2D Proteins (9) and many more products for this protein. A total of 89 CDKN2D products are currently listed.
ank2, CDKN2D, INK4d, p19, p19-INK4D, p19INK4d
list all antibodies Gene Name GeneID UniProt
CDKN2D 1032 P55273
CDKN2D 12581 Q60773
CDKN2D 494444  

Show all species

Show all synonyms

Most Popular Reactivities for anti-CDKN2D (CDKN2D) Antibodies

Select your species and application

anti-Human CDKN2D Antibodies:

anti-Mouse (Murine) CDKN2D Antibodies:

anti-Rat (Rattus) CDKN2D Antibodies:

All available anti-CDKN2D Antibodies

Go to our pre-filtered search.

Top referenced anti-CDKN2D Antibodies

  1. Human Monoclonal CDKN2D Primary Antibody for WB - ABIN393412 : Cunningham, Vierkant, Sellers, Phelan, Rider, Liebow, Schildkraut, Berchuck, Couch, Wang, Fridley, Gentry-Maharaj, Menon, Hogdall, Kjaer, Whittemore, DiCioccio, Song, Gayther, Ramus, Pharaoh, Goode: Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. in British journal of cancer 2009 (PubMed)
    Show all 5 references for 393412

  2. Human Monoclonal CDKN2D Primary Antibody for IF, IHC (p) - ABIN1106659 : Hirai, Roussel, Kato, Ashmun, Sherr: Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. in Molecular and cellular biology 1995 (PubMed)
    Show all 2 references for 1106659

  3. Human Monoclonal CDKN2D Primary Antibody for IHC (p), IP - ABIN487338 : Thullberg, Welcker, Bartkova, Kjerulff, Lukas, Högberg, Bartek: Monoclonal antibody probes for p21WAF1/CIP1 and the INK4 family of cyclin-dependent kinase inhibitors. in Hybridoma 2000 (PubMed)

  4. Human Polyclonal CDKN2D Primary Antibody for IHC, ELISA - ABIN1533788 : Okuda, Hirai, Valentine, Shurtleff, Kidd, Lahti, Sherr, Downing: Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases. in Genomics 1996 (PubMed)

More Antibodies against CDKN2D Interaction Partners

Human Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) interaction partners

  1. We unexpectedly found that p19INK4d plays an important role in human terminal erythropoiesis

  2. p19(INK4D) is one of the key mediators of miR (show MLXIP Antibodies)-125b activity during the onset of megakaryocyte polyploidization.

  3. p19 may play an important role in the ototoxic effects of cisplatin and is probably involved in the pathogenesis of hearing loss.

  4. MiR (show MLXIP Antibodies)-451 inhibited the proliferation of esophageal squamous cell carcinoma cells by targeting CDKN2D and MAP3K1 (show MAP3K1 Antibodies) expression.

  5. Data indicate that upon oxidative DNA damage, cyclin-dependent kinase (show CDK1 Antibodies) inhibitor p19INK4d strongly binds to and relaxes chromatin.

  6. CDKN2D repression by PML (show PML Antibodies)/RARalpha (show RARA Antibodies) disrupts both cell proliferation and differentiation in the pathogenesis of acute promyelocytic leukemia (show PML Antibodies).

  7. p19-INK4d inhibits neuroblastoma (show ARHGEF16 Antibodies) cell growth, induces differentiation and is hypermethylated and downregulated in MYCN (show MYCN Antibodies)-amplified neuroblastomas.

  8. CDKN2D-WDFY2 (show ZFYVE22 Antibodies) fusion could be an important molecular signature for understanding and classifying sub-lineages among heterogeneous high-grade serous ovarian carcinomas.

  9. Mutations in CDKN2D is associated with sporadic parathyroid adenoma.

  10. P19(INK4d) expression is a poor prognostic factor in ovarian cancer patients.

Mouse (Murine) Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D) interaction partners

  1. TWIST1 (show TWIST1 Antibodies)-E protein heterodimeric complexes may thus constitute the main active forms of TWIST1 (show TWIST1 Antibodies) with regard to senescence inhibition over the time course of breast tumorigenesis.

  2. Rescue from early-onset hearing loss in a mouse model lacking the cyclin-dependent kinase (show CDK1 Antibodies) inhibitor p19Ink4d.

  3. p19 INK4d controls hematopoietic stem cells in a cell-autonomous manner during genotoxic stress and through the microenvironment during aging

  4. Cdk4 (show CDK4 Antibodies) and Cdk6 (show CDK6 Antibodies) cooperate in hematopoietic tumor development and suggest a role for Cdk6 (show CDK6 Antibodies) in sequestering INK4 (show CDKN2A Antibodies) proteins away from Cdk4 (show CDK4 Antibodies).

  5. Deletion of p19(Ink4d) (p19), a cyclin-dependent kinase (show CDK1 Antibodies) CDK (show CDK4 Antibodies) inhibitor gene, in mice results in spontaneous development of tumors in multiple organs and tissues.

  6. We propose that p19INK4d participates in the cellular mechanisms that trigger senescence by contributing to chromatin compaction

  7. CDK5 (show CDK5 Antibodies)-mediated phosphorylation of p19INK4d avoids DNA damage-induced neurodegeneration in mouse hippocampus and prevents loss of cognitive functions.

  8. an asymmetrical distribution pattern for Cdkn2d transcripts in 2-cell embryos.

  9. Ectopic expression of RUVBL2 (show RUVBL2 Antibodies) decreases the levels of ARF (show CDKN2A Antibodies), whereas knockdown of RUVBL2 (show RUVBL2 Antibodies) results in a marked increase in ARF (show CDKN2A Antibodies) levels. In addition, RUVBL2 (show RUVBL2 Antibodies) down-regulates the levels of p53 (show TP53 Antibodies) in an ARF (show CDKN2A Antibodies)-dependent manner.

  10. DeltaNp63alpha has oncogenic activity and its overexpression in human squamous cell carcinomas contributes to the malignant phenotype, and implicate its ability to regulate p16(ink4a)/p19(arf (show CDKN2A Antibodies)) in the process.

CDKN2D Antigen Profile

Antigen Summary

The protein encoded by this gene is a member of the INK4 family of cyclin-dependent kinase inhibitors. This protein has been shown to form a stable complex with CDK4 or CDK6, and prevent the activation of the CDK kinases, thus function as a cell growth regulator that controls cell cycle G1 progression. The abundance of the transcript of this gene was found to oscillate in a cell-cycle dependent manner with the lowest expression at mid G1 and a maximal expression during S phase. The negative regulation of the cell cycle involved in this protein was shown to participate in repressing neuronal proliferation, as well as spermatogenesis. Two alternatively spliced variants of this gene, which encode an identical protein, have been reported.

Alternative names and synonyms associated with CDKN2D

  • cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) (cdkn2d) antibody
  • cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) (CDKN2D) antibody
  • Cyclin-dependent kinase 4 inhibitor D (cdn2d) antibody
  • cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) (Cdkn2d) antibody
  • similar to cyclin-dependent kinase inhibitor 2D (Cdkn2d) antibody
  • ank2 antibody
  • CDKN2D antibody
  • INK4d antibody
  • p19 antibody
  • p19-INK4D antibody
  • p19INK4d antibody

Protein level used designations for CDKN2D

cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) , cyclin-dependent kinase 4 inhibitor D , Cyclin-dependent kinase 4 inhibitor D , CDK inhibitor p19INK4d , cell cycle inhibitor, Nur77 associating protein , cyclin-dependent kinase 4 inhibitor D p19 , inhibitor of cyclin-dependent kinase 4d , p19-INK4d

446719 Xenopus laevis
611216 Canis lupus familiaris
713172 Macaca mulatta
745942 Pan troglodytes
780300 Xenopus (Silurana) tropicalis
100196083 Salmo salar
1032 Homo sapiens
12581 Mus musculus
510244 Bos taurus
494444 Rattus norvegicus
Selected quality suppliers for anti-CDKN2D (CDKN2D) Antibodies
Did you look for something else?